Letrozole Tablet, Film Coated
Product Images NDC 23155-875

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 23155-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (11005a48 13fd 4c6d A024 1e39e3528e45 01)

Figure-1 (11005a48 13fd 4c6d A024 1e39e3528e45 01)
FDA Label Image

Avet.jpg (Avet)

Avet.jpg (Avet)
FDA Label Image

Figure-2 (Figure 1 Disease Free Survival Median Follow Up 73 Months Itt Approach)

Figure-2 (Figure 1 Disease Free Survival Median Follow Up 73 Months Itt Approach)
FDA Label Image

Figure-3 (Figure 2 Kaplan Meier Estimates Of Time To Progression Tamoxifen Study)

Figure-3 (Figure 2 Kaplan Meier Estimates Of Time To Progression Tamoxifen Study)
FDA Label Image

Figure-4 (Figure 3 Survival By Randomized Treatment Arm)

Figure-4 (Figure 3 Survival By Randomized Treatment Arm)
FDA Label Image

Figure-5 (Figure 4 Kaplan Meier Estimates Of Time To Progression Megestrol Acetate Study)

Figure-5 (Figure 4 Kaplan Meier Estimates Of Time To Progression Megestrol Acetate Study)
FDA Label Image

Figure-6 (Figure 5 Kaplan Meier Estimates Of Time To Progression Amino)

Figure-6 (Figure 5 Kaplan Meier Estimates Of Time To Progression Amino)
FDA Label Image

Figure 6

Figure 6
FDA Label Image

Label (Label 1000s)

Label (Label 1000s)
FDA Label Image

Label 30s.jpg (Label 30s)

Label 30s.jpg (Label 30s)
FDA Label Image

Label 90s.jpg (Label 90s)

Label 90s.jpg (Label 90s)